| Ki |
- |
| EC50 |
|
| IC50 |
0.62±0.01μM(RatAChE), 62.0±0.72μM( RatBCHE), 0.25±0.03μM(HuAChE) |
| Inhibition |
62.2±1.8%( human AChE-induced Aβ1-40 aggregation), 85.7±2.5%( Cu2+-induced Aβ1-42 aggregation ), 69.1±1.8%( self-induced Aβ1-42 aggregation) |
| Toxicity |
|
| ROS(reactive oxygen species) |
0.84 |
| Metal Chelating |
Cu2+ |
| BBB(blood-brain barrier) |
|
| Target Protein |
Butyrylcholinesterase (BChE) |
| Effects |
Demonstrated significant metal chelating properties, moderate acetylcholinesterase(AChE) inhibitory and anti-oxidative activity, and excellent inhibitory effects on self-induced Aβ1-42 aggregation, Cu2+-induced Ab1-42 aggregation, human AChE-induced Aβ1-40 aggregation and disassembled Cu2+-induced aggregation of the well-structured Aβ1-42 fibrils. |
| Research Models |
In PC12 cell , in SH-SY5Y cell, in mice |
| Ref. Link |
|